elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Intrahepatic Cholangiocarcinoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Intrahepatic Cholangiocarcinoma
RIS
0.001
(Research Intensity Score)
Papers
162
Top papers
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
2022 · 333 citations
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
2022 · 250 citations
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
2024 · 53 citations
SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.
2023 · 99 citations
Systemic therapies for intrahepatic cholangiocarcinoma
2020 · 442 citations
Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis
2024 · 41 citations
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
2019 · 475 citations
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers
2024 · 35 citations
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma
2022 · 101 citations
Newest papers
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301
2026 · 3 citations
Yttrium-90 Transarterial Radioembolization for Intrahepatic Cholangiocarcinoma: A Comprehensive Review
2026 · 2 citations
The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review
2026
Intratumoral IDH1 mutation status in intrahepatic cholangiocarcinoma is homogeneous
2026
Trends and disparities in intrahepatic cholangiocarcinoma mortality in the United States, 1999–2024: a CDC WONDER analysis
2026
Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis
2026
Development of a preoperative prediction model for non-curative resection in intrahepatic cholangiocarcinoma involving the hepatic hilum
2026
PROACTIF: Final results from the largest prospective real-world study of 1196 primary liver cancer patients (PLC) treated with yttrium-90 (Y90) glass transarterial radioembolization (TARE).
2026 · 2 citations
Mixed-Reality Intraprocedural Guidance for Transradial Yttrium-90 Radiation Segmentectomy of Intrahepatic Cholangiocarcinoma: Initial Clinical Experience
2026 · 1 citations
Browse all papers →
Intrahepatic Cholangiocarcinoma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Intrahepatic Cholangiocarcinoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link